Michael D. Schneider
Director/Miembro de la Junta en The Medical Research Council .
Cargos activos de Michael D. Schneider
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Director/Miembro de la Junta | 12/07/2011 | - |
Historial de carrera de Michael D. Schneider
Antiguos cargos conocidos de Michael D. Schneider.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| British Heart Foundation | Corporate Officer/Principal | 14/05/2010 | - |
| Baylor College of Medicine | Corporate Officer/Principal | 01/01/1984 | - |
The National Heart & Lung Institute
 The National Heart & Lung Institute Miscellaneous Commercial ServicesCommercial Services The National Heart & Lung Institute provided medical educational services. The company was headquartered in London, the United Kingdom. | Corporate Officer/Principal | 14/05/2010 | - |
Kardia Therapeutics, Inc.
 Kardia Therapeutics, Inc. BiotechnologyHealth Technology Kardia Therapeutics, Inc. develops cardiac regenerative therapies. It focuses in the areas of myocardial infarction and heart failure. The firm's portfolio of technologies utilizes three related approaches which include adult cardiac progenitor cells, stem cell optimization technologies, and homing/growth factor therapies. The company was founded by Michael D. Schneider and Robert J. Schwartz in 2002 and is headquartered in Houston, TX. | Director/Miembro de la Junta | 01/01/2002 | - |
| Fundador | 17/08/2009 | - |
Formación de Michael D. Schneider.
| University of Pennsylvania | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Reino Unido | 4 |
Operativa
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Founder | 1 |
Sectorial
| Commercial Services | 4 |
| Consumer Services | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Kardia Therapeutics, Inc.
Kardia Therapeutics, Inc. BiotechnologyHealth Technology Kardia Therapeutics, Inc. develops cardiac regenerative therapies. It focuses in the areas of myocardial infarction and heart failure. The firm's portfolio of technologies utilizes three related approaches which include adult cardiac progenitor cells, stem cell optimization technologies, and homing/growth factor therapies. The company was founded by Michael D. Schneider and Robert J. Schwartz in 2002 and is headquartered in Houston, TX. | Health Technology |
The National Heart & Lung Institute
The National Heart & Lung Institute Miscellaneous Commercial ServicesCommercial Services The National Heart & Lung Institute provided medical educational services. The company was headquartered in London, the United Kingdom. | Commercial Services |
| British Heart Foundation | Commercial Services |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
- Bolsa de valores
- Insiders
- Michael D. Schneider
- Experiencia
